arginine vasopressin has been researched along with quinazolines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, T; Ishizaki, T; Murabayashi, S; Tomiyama, T | 1 |
| Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Corvera, S; García-Sáinz, JA | 1 |
| Keshavan, V; Shanthi, M; Tyagi, MG; Vikram, GS | 1 |
| Furube, E; Itoh, M; Mannari, T; Miyata, S; Morita, S; Nishikawa, K; Yoshida, A | 1 |
| Acaz-Fonseca, E; Garcia-Segura, LM; Ghorbanpoor, S; Grassi, D; Ruiz-Palmero, I | 1 |
1 trial(s) available for arginine vasopressin and quinazolines
| Article | Year |
|---|---|
Acute effect of an alpha 1-adrenoceptor antagonist on urinary sodium excretion, plasma atrial natriuretic peptide, arginine vasopressin, and the renin-aldosterone system in healthy subjects.
Topics: Adrenergic alpha-Antagonists; Adult; Arginine Vasopressin; Atrial Natriuretic Factor; Enalapril; Humans; Male; Premedication; Quinazolines; Renin-Angiotensin System; Sodium | 1992 |
5 other study(ies) available for arginine vasopressin and quinazolines
| Article | Year |
|---|---|
Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Bradycardia; Catecholamines; Deamino Arginine Vasopressin; Heart Rate; Male; Methoxamine; Prazosin; Pressoreceptors; Quinazolines; Rats; Renin; Saralasin | 1983 |
Hypothyroidism abolishes the glycogenolytic effect of vasopressin, angiotensin II and A23187 but not that of alpha 1-adrenergic amines in rat hepatocytes.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcimycin; Epinephrine; Female; Hypothyroidism; Kinetics; Liver; Liver Glycogen; Prazosin; Quinazolines; Rats; Rats, Inbred Strains | 1983 |
Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heart Rate; Injections, Intraperitoneal; Injections, Intravenous; Lithium Carbonate; Lypressin; Mice; Motor Activity; Neomycin; Phospholipids; Piperidines; Polyuria; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Sphingosine | 2004 |
VEGF-dependent and PDGF-dependent dynamic neurovascular reconstruction in the neurohypophysis of adult mice.
Topics: Animals; Arginine Vasopressin; Cell Proliferation; Endothelium, Vascular; Male; Mice; Mice, Inbred C57BL; Models, Animal; Neovascularization, Physiologic; Neuroglia; Oxytocin; Pituitary Gland, Posterior; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Quinazolines; Signal Transduction; Vascular Endothelial Growth Factor A | 2014 |
The Selective Estrogen Receptor Modulator Raloxifene Regulates Arginine-Vasopressin Gene Expression in Human Female Neuroblastoma Cells Through G Protein-Coupled Estrogen Receptor and ERK Signaling.
Topics: Arginine Vasopressin; Blotting, Western; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Neuroblastoma; Phosphorylation; Protein Kinase C; Pyrroles; Quinazolines; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Selective Estrogen Receptor Modulators | 2015 |